{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:40:37Z","timestamp":1788910837772,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bbrc.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T03:48:01Z","timestamp":1621050481000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance"],"prefix":"10.1016","volume":"561","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4226-9177","authenticated-orcid":false,"given":"Yuko","family":"Takeshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Motohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Kadomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunie","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Oike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Katabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-2456","authenticated-orcid":false,"given":"Motoyoshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.05.008_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41389-020-0209-0","article-title":"PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via \u03b15\u03b21 integrin and JNK\/IL-8 signaling","volume":"9","author":"Siu","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbrc.2021.05.008_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2021.05.008_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2021.05.008_bib4","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.05.008_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.21873\/cgp.20004","article-title":"Mechanisms and targets involved in dissemination of ovarian cancer","volume":"13","author":"Weidle","year":"2016","journal-title":"CANCER GENOMICS PROTEOMICS"},{"key":"10.1016\/j.bbrc.2021.05.008_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070907","article-title":"Ovarian cancer stemness: biological and clinical implications for metastasis and chemotherapy resistance","volume":"11","author":"Motohara","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2021.05.008_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/cas.12765","article-title":"CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer","volume":"106","author":"Tjhay","year":"2015","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2021.05.008_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tem.2014.03.012","article-title":"Diverse roles of ANGPTL2 in physiology and pathophysiology","volume":"25","author":"Kadomatsu","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","article-title":"Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance","volume":"10","author":"Tabata","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib10","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.5301\/jbm.5000080","article-title":"Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis","volume":"29","author":"Endo","year":"2014","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.bbrc.2021.05.008_bib11","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/0008-5472.CAN-11-3878","article-title":"Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis","volume":"72","author":"Endo","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib12","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1038\/srep09170","article-title":"ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling","volume":"5","author":"Masuda","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2021.05.008_bib13","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1158\/0008-5472.CAN-11-1758","article-title":"Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis","volume":"71","author":"Aoi","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib15","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2021.05.008_bib16","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcb.26363","article-title":"Anoikis resistance and oncoviruses","volume":"119","author":"Kakavandi","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2021.05.008_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12185-008-0215-z","article-title":"Early development of human hematopoietic and acquired immune systems in new born NOD\/Scid\/Jak3null mice intrahepatic engrafted with cord blood-derived CD34\u00a0+ cells","volume":"88","author":"Okada","year":"2008","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib18","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/0008-5472.CAN-08-0062","article-title":"Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer","volume":"68","author":"Kikuchi","year":"2008","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer","volume":"31","author":"Masoumi Moghaddam","year":"2012","journal-title":"Canc. Metastasis Rev."},{"issue":"Pt 1","key":"10.1016\/j.bbrc.2021.05.008_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1242\/jcs.101.1.145","article-title":"The \u03b24 subunit of the integrin family is displayed on a restricted subset of endothelium in mice","volume":"101","author":"Kennel","year":"1992","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2021.05.008_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1083\/jcb.117.3.671","article-title":"The integrin \u03b16\u03b24 is a laminin receptor","volume":"117","author":"Lee","year":"1992","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nature02765","article-title":"Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB","volume":"430","author":"Douma","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.05.008_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","article-title":"Integrins and anoikis","volume":"9","author":"Frisch","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2021.05.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2021.03.038","article-title":"The hallmarks of ovarian cancer stem cells and niches: exploring their harmonious interplay in therapy resistance","author":"Motohara","year":"2021","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004612","article-title":"The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin \u03b15\u03b21, p38 MAPK, and matrix metalloproteinases","volume":"7","author":"Odagiri","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2021.05.008_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061466","article-title":"Therapeutic targeting of collective invasion in ovarian cancer","volume":"20","author":"Moffitt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2021.05.008_bib28","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib29","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/onc.2016.509","article-title":"A\u00a0loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNF\u03b1-TGF\u03b1-EGFR","volume":"36","author":"Lau","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.05.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.08.030","article-title":"Laminin-induced signaling in tumor cells","volume":"223","author":"Givant-Horwitz","year":"2005","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2021.05.008_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O","article-title":"Integrins as receptors for laminins","volume":"51","author":"Belkin","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.bbrc.2021.05.008_bib32","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/0008-5472.CAN-06-2980","article-title":"The \u03b16\u03b24 integrin can regulate ErbB-3 expression: implications for \u03b16\u03b24 signaling and function","volume":"67","author":"Folgiero","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib33","first-page":"181","article-title":"Integrins in cell adhesion and signaling","volume":"9","author":"Akiyama","year":"1996","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bbrc.2021.05.008_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","article-title":"Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors","volume":"5","author":"Schaffner","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2021.05.008_bib35","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.R000003200","article-title":"Ligand binding to integrins","volume":"275","author":"Plow","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.05.008_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2021.05.008_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/306879","article-title":"Anoikis resistance: an essential prerequisite for tumor metastasis","volume":"2012","author":"Kim","year":"2012","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.bbrc.2021.05.008_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jss.2008.05.017","article-title":"ERK\/BCL-2 pathway in the resistance of pancreatic cancer to anoikis","volume":"152","author":"Galante","year":"2009","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-3011.1990.tb00261.x","article-title":"Receptor selectivity of enkephalin analogs carrying artificial address peptides","volume":"35","author":"Kimura","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.bbrc.2021.05.008_bib40","doi-asserted-by":"crossref","first-page":"48342","DOI":"10.1074\/jbc.M407953200","article-title":"Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin \u03b1v mediate survival signals through focal adhesion kinase","volume":"279","author":"Zhang","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.05.008_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1242\/jcs.00231","article-title":"\u03b15\u03b21 integrin mediates strong tissue cohesion","volume":"116","author":"Robinson","year":"2003","journal-title":"J.\u00a0Cell Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21007774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21007774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:05:39Z","timestamp":1757765139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21007774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":41,"alternative-id":["S0006291X21007774"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.008","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}